Senior Director, National Head, Field Medical Affairs jobs in United States
cer-icon
Apply on Employer Site
company-logo

BridgeBio · 9 hours ago

Senior Director, National Head, Field Medical Affairs

BridgeBio is a pioneering biotech company focused on advancing groundbreaking medicines for rare diseases. The Senior Director, National Field Medical Lead will be responsible for leading the Field Medical Affairs organization, shaping medical strategy, and ensuring compliant execution in support of medical objectives and stakeholder engagement.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
check
Growth Opportunities

Responsibilities

Develop, operationalize, and execute a national field medical strategy aligned to Calcilytix Medical Affairs objectives and program priorities
Lead field medical launch readiness planning, including field tool development, scientific narrative alignment, and readiness for congress and other high-impact external engagement
Provide leadership to the field-based Medical Affairs organization, including recruiting, onboarding, coaching, mentoring, and performance development
Define expectations and quality standards for field excellence (engagement planning, documentation, insight quality, congress execution, and stakeholder follow-through)
Build and maintain strategic relationships with national and regional endocrinology key opinion leaders (KOLs), investigators, academic centers, specialty clinics, and other influential stakeholders
Ensure delivery of high-quality, compliant scientific exchange with healthcare providers and external stakeholders, including disease biology, emerging clinical data, trial activity, unmet need, and the Calcilytix pipeline
Support Calcilytix-sponsored and investigator-initiated research (IIR), including site identification, feasibility input, investigator engagement, and appropriate clinical/scientific support

Qualification

Advanced scientific degreeMedical Affairs experienceEndocrinology backgroundClinical research understandingAnalytical skillsCommunication skillsRelationship building skillsOrganizational skillsInterpersonal skills

Required

Advanced scientific or clinical degree required (MD, DO, PharmD, or PhD)
8+ years of Medical Affairs and/or Field Medical experience with demonstrated track record of excellence
Strong communication, presentation, relationship building, organizational, analytical, and interpersonal skills
Deep understanding of clinical research and pharmaceutical development processes
Ability to comply with all internal policies and external regulations, including those related to travel, expenses, and compliance
Comfort working independently in a dynamic, fast-paced environment; 60-75% travel required

Preferred

Background in endocrinology and/or rare disease experience strongly preferred

Benefits

401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

Company

BridgeBio

twittertwittertwitter
company-logo
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Funding

Current Stage
Public Company
Total Funding
$4.35B
Key Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
2024-01-18Post Ipo Debt· $1.25B

Leadership Team

leader-logo
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
linkedin
leader-logo
Neil Kumar
CEO and Founder
linkedin
Company data provided by crunchbase